Loading...
WCLC congresses_Older2025-01-28T16:41:13+01:00

WCLC 2018 – Toronto

Lecture Board: Heidi A. Hamann, PhD; Vera Hirsh, MD; Maximilian Hochmair, MD; Herbert Ho Fung Loong, MD
Medical Writer: Dr. Judith Moser

DOWNLOADS

All downloads from WCLC 2018

WCLC 2018 English

Full report (english)

WCLC 2018 Mandarin

Full report (mandarin)

WCLC 2018 Japanese

Full report (japanese)

EXPERT VIDEOS

All video interviews from WCLC 2018

Herbert Loong on peculiarities of lung cancer research with a focus on phase I studies.

James Ho talks about novel diagnostic approaches, monitoring of lung cancer patients as well as the potential for the use of antioxidants in lung cancer.

Maximilian Hochmair on the future of combinations of immunotherapies with other drugs as well as his recommendations for treatment sequencing in ALK-positive and EGFR-positive lung cancer.

Vera Hirsh discusses the latest clinical achievements using <em>EGFR</em>-targeted therapy in patients with advanced NSCLC and the role of patient quality of life.

This is the first study in more than 20 years to show a clinically meaningful survival improvement over the current first-line standard of care in this setting. A singular survival benefit has also been obtained with durvalumab in unresectable, stage III non–small-cell lung cancer.

Vera Hirsh • MD, Department of Oncology, McGill University Health Center, Montreal, Canada

WCLC 2017 – Yokohama

Lecture Board: John Edwards, MB,ChB,PhD; Maximilian Hochmair, MD
Medical Writer: Dr. Judith Moser

DOWNLOADS

All downloads from WCLC 2017

WCLC 2017 English

Full report (english)

WCLC 2017 Mandarin

Full report (mandarin)

WCLC 2017 Japanese

Full report (japanese)

EXPERT VIDEOS

All video interviews from WCLC 2017

David Gandara discusses the latest progress in EGFR, ALK, and checkpoint inhibitor therapies for NSCLC.

Keunchil Park discusses how lung cancer treatments have developed since the advent of chemotherapy, and how best to deliver optimal care to lung cancer patients worldwide, and specifically in South Korea and Japan.

Ramaswamy Govindan discusses the importance of chemotherapy in today’s treatment landscape, and the importance of ethnic genomic differences in mutation rates in lung cancer.

Paul A. Bunn discusses current and future treatment options in lung cancer.

Clinical trials conducted in Asia have contributed considerably to the development of targeted therapies, such as EGFR or ALK tyrosine kinase inhibitors, and immunotherapies, but also to the implementation of cytotoxic drugs. Particularly in lung cancer, Eastern Asia has evolved into a stronghold of cancer research over the previous years.

Fred R. Hirsch • MD • PhD, Dep. of Pneumology, Hopitaux Universitaires de Strasbourg

WCLC 2016 – Vienna

Lecture Board: David P. Carbone, MD, PhD; Maximilian Hochmair, MD; Martin Filipits, MD; Anders Mellemgaard, MD, PhD;
Remón Rami-Porta, MD; Benjamin Solomon, MBBD, PhD; Johan Vansteenkiste, MD
Medical Writer: Dr. Judith Moser

DOWNLOADS

All downloads from WCLC 2016

WCLC 2016 English

Full report (english)

WCLC 2016 Spanish

Full report (spanish)

WCLC 2016 Mandarin

Full report (mandarin)

WCLC 2016 Japanese

Full report (japanese)

EXPERT VIDEOS

All video interviews from WCLC 2016

Martin Schuler on the current state-of-play for EGFR diagnostic technologies

Johan Vansteenkiste discusses the practical considerations for immunotherapy

Robert Pirker on the hot topics in lung cancer research on the agenda at the IASLC 2017 WCLC congress

Fiona Blackhall on the importance of molecular diagnosis on the diagnosis and follow up of lung cancer

James Chih-Hsin Yang talks TKIs

The international nature of the IASLC and the pace of progress in the field of lung cancer have prompted us to move annual world conferences, as well as annual regional meetings. We are hoping to make the IASLC WCLC the established platform for the interdisciplinary, international dissemination of the state of the art in lung cancer research.

David P. Carbone • MD • Phd, Dep. of Pneumology, Hopitaux Universitaires de Strasbourg
Go to Top